CHIASMA
Chiasma applies its proprietary technology to approved drugs, which not only enables their being switched from injectable to oral, but importantly can result in new indications and/or enhanced absorption. The Company's Transient Permeability Enhancer technology promotes the delivery of drugs to the GI wall and from there to the liver. It is applicable to macromolecules that to-date can be administered only by injection. TPE can be utilized also with small molecules that are already orally available but are poorly absorbed.
CHIASMA
Industry:
Biopharma Biotechnology Therapeutics
Founded:
2001-01-01
Address:
Waltham, Massachusetts, United States
Country:
United States
Website Url:
http://www.chiasma.com
Total Employee:
51+
Status:
Active
Contact:
972 2 571 5885
Total Funding:
246 M USD
Technology used in webpage:
SPF Microsoft Exchange Online Office 365 Mail IPv6 IIS Pound Sterling Microsoft ASP.NET 4.0 Microsoft Azure ASP.NET Ajax
Similar Organizations
Boston Immune Technologies & Therapeutics
This company is a Boston-based biopharmaceutical company developing immune-based approaches.
DiaMedica
DiaMedica is a biopharmaceutical company focused on developing innovative treatments for stroke.
Emmaus Medical
Emmaus Medical is a pharmaceutical company developing new treatments for rare diseases and conditions.
Manus Bio
Manus Bio makes nature accessible and affordable for a growing society.
Relypsa
Relypsa is a biopharmaceutical company developing drugs for treating cardiovascular and renal diseases.
Renovis
Renovis,is a biopharmaceutical company developing drugs to treat neurological diseases and disorders.
SAJE Pharma
SAJE Pharma is a bio-pharmaceutical company developing therapeutic agents for respiratory diseases.
SpringWorks Therapeutics
SpringWorks Therapeutics is a biopharmaceutical company that develops medicines for patients with severe rare diseases and cancer.
Thesan Pharmaceuticals
Thesan Pharmaceuticals is a preclinical biopharmaceutical company developing novel therapeutics for skin disorders.
Transition Therapeutics
Transition Therapeutics is a biopharmaceutical company developing novel therapeutics for disease indications with large markets.
Triana Biomedicines
Triana Biomedicines is a developer of a molecular glue discovery platform to regulate disease.
Current Advisors List
Board_member
Board_member
Board_member
Board_member
2007-10-01
Board_member
Current Employees Featured
Asi Haviv VP of Clinical Development @ Chiasma
VP of Clinical Development
2012-01-01
Shoshie Katz VP RA/QA @ Chiasma
VP RA/QA
2011-12-01
Gary Patou Head of Clinical @ Chiasma
Head of Clinical
2014-01-01
Anand Varadan EVP, Chief Commercial Officer @ Chiasma
EVP, Chief Commercial Officer
Stock Details
Investors List
Poalim Equity
Poalim Equity investment in Post-IPO Equity - Chiasma
Blue Chip Venture Company
Blue Chip Venture Company investment in Series E - Chiasma
Abingworth
Abingworth investment in Series E - Chiasma
Sofinnova Investments
Sofinnova Investments investment in Series E - Chiasma
Rock Springs Capital
Rock Springs Capital investment in Series E - Chiasma
ARCH Venture Partners
ARCH Venture Partners investment in Series E - Chiasma
F2 Ventures
F2 Ventures investment in Series E - Chiasma
MPM Capital
MPM Capital investment in Series E - Chiasma
7 Health Ventures
7 Health Ventures investment in Series E - Chiasma
Abingworth
Abingworth investment in Series D - Chiasma
Official Site Inspections
http://www.chiasma.com Semrush global rank: 7.45 M Semrush visits lastest month: 492
- Host name: 172.67.153.113
- IP address: 172.67.153.113
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Chiasma"
Chiasma - Crunchbase Company Profile & Funding
Chiasma applies its proprietary technology to approved drugs, which not only enables their being switched from injectable to oral, but importantly can result in new indications and/or enhanced …See details»
Chiasma, Inc. - AnnualReports.com
Chiasma is focused on developing and commercializing oral therapies to improve the lives of patients who face challenges associated with their existing …See details»
Chiasma
Avec Chiasma notamment, il tente de promouvoir l'esprit scientifique comme posture mentale, accessible à tous, à la fois orfèvre de la connaissance - permettant de dépasser nos …See details»
Chiasma - Org Chart, Teams, Culture & Jobs - The Org
Chiasma is a late-stage biopharmaceutical company focused on improving the lives of patients suffering from orphan diseases by developing and commercializing novel oral forms of …See details»
Chiasma - Products, Competitors, Financials, Employees, …
Chiasma. Frequently Asked Questions (FAQ) When was Chiasma founded? Chiasma was founded in 2001. Where is Chiasma's headquarters? Chiasma's headquarters is located at …See details»
Chiasma: Revenue, Worth, Valuation & Competitors 2024
About Chiasma. Chiasma is a Biotech related company based in Needham with 26 employees an estimated revenue of $2M, and. It has 11 competitors including Synapsis, Dermavant …See details»
Chiasma, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
Explore Chiasma, Inc. with its drug pipeline, therapeutic area, technology platform, 7 clinical trials, 32 news, and 25 literature, Drug:CHIP-2, CH-3 (Chiasma). ... The statistics for drugs in the …See details»
Chiasma Company Overview, Contact Details & Competitors
At Chiasma, we remain resilient in the face of challenges. Leveraging our delivery technology, Transient Permeability Enhancer (TPE®), we work every day to create innovative solutions to …See details»
Team - Chiasma
During his PhD, he focused on the way the brain adapts to blindness. Sami finds data fascinating, works as a data scientist and spends a some of his free time finding insights about human …See details»
Chiasma - Crunchbase
Chiasma is a biopharmaceutical company developing oral drugs for the treatment of orphan diseases.See details»
Chiasma, Inc. (Chiasma, Inc.) - 药物管线_专利_临床试验_投融营收
In the first half of 2024, Rybelsus achieved sales of $1.587 billion, representing a 32% year-over-year growth. Equally noteworthy is the Israeli pharmaceutical company Chiasma Inc., which …See details»
Chiasma Reports Fourth Quarter and Full-Year 2020 Financial
Mar 4, 2021 Chiasma, Inc. Condensed Consolidated Balance Sheets Information (amounts in thousands) (unaudited) December 31, 2020 December 31, 2019See details»
Chiasma Management Team - CB Insights
Explore {Chiasma's key management people. Discover current leadership team members including founders, CEO, other executives and board directors. Chiasma CEO, Founder, Key …See details»
Chiasma Announces Planned Transition of Former CEO - Yahoo …
Oct 1, 2020 Chiasma, Inc. (NASDAQ: CHMA), a commercial stage biopharmaceutical company utilizing its delivery platform technology to develop and commercialize oral therapies to reduce …See details»
F2 Ventures - Investments, Portfolio & Company Exits - Crunchbase
How many investments has this organization made over time? Show . Which industries has this organization most actively invested in? Show . Announced Date . Organization Name . Lead …See details»
CHIASMA
It relates to a very interesting part of our brain, the Optic Chiasma (or Chiasm) where the optic nerves cross. Visual information such as light and movement in the right visual field goes to …See details»
Chiasma: A Site For Thought - uwo.ca
As we start off 2025, Chiasma Vol. 9 (Philosophy / Fascism / State) is officially available! We have some truly excellent texts, and all contributions bring something incredibly unique and …See details»
Chiasma - LinkedIn
Chiasma focuses on how we form our opinions and what shapes them as they are a central component of our decision making. Being able to evaluate the different sources of information …See details»
[[en]]Resources [[fr]]Ressources - Chiasma
Chiasma event at The Bureau in partnership with The Boson Project, filmed by La Monade. Nous allons suivre un scenario pour essayer de comprendre comment une opinion pourrait se …See details»
Chiasma Volume 9 Now Available! | Chiasma: A Site For Thought
Jan 1, 2025 Chiasma Volume 9 Now Available! Chiasma Volume 9 Now Available! 2025-01-01 As we start off 2025, Chiasma Vol. 9 (Philosophy / Fascism / State) is officially available! We …See details»